[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy

A technology of cyclohexane carbonyl compound, which is applied in the field of coolant and drug therapy, can solve the problems of lozenge, nausea, irritation, limited application, etc.

Active Publication Date: 2015-06-17
AXALBION SA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, on nonkeratinizing epithelial cells, menthol's irritating effects limit its use; for example, lozenges containing more than 8 mg menthol per unit taste disgusting

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
  • [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
  • [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] compound

[0030] The present inventors have discovered that certain compounds are surprising and unexpectedly effective cooling agents for non-keratinized stratified epithelial (NKSE) tissue. These compounds are effective and long-acting and selectively cooling on non-keratinized epithelial tissue compared to keratinized epithelial tissue.

[0031] These compounds are collectively referred to herein as "isopropyl ester compounds" or "IPE compounds" and are:

[0032] [((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-isopropyl acetate ("Gly-O-iPr") and

[0033] [((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexanecarbonyl)-methyl-amino]-isopropyl acetate ("N-Gly-O-iPr");

[0034] And its pharmaceutically acceptable salts, hydrates, and solvates.

[0035] Thus, one aspect of the invention is the following compounds:

[0036] [((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-isopropyl acetate ("Gly-O-iPr") or

[0037] [((1R,2S,5R)-2-Isopropyl-5-methyl-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention pertains generally to the field of coolants and medical therapy. More particularly, the present invention relates to certain anti-nociceptive agents, such as [((1R,2S,5f?)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester, that are potent and long-acting and selectively cooling for non-keratinized epithelial tissues as compared to keratinized epithelial tissues, and are useful, for example, for the treatment of (e.g., the alleviation of symptoms of; the amelioration of) sensory discomfort of non-keratinized stratified epithelial (NKSE) tissue; and so for treatment of: sensory discomfort of an ocular surface, an eyelid, a margin of an eyelid, an anterior part of an eyeball, a conjunctiva, a lachrymal system, a pre-corneal film, or a cornea, a lining of the oral cavity, an internal portion of the lips, a pharyngeal surface, an esophageal surface, or an anogenital surface; eye discomfort, e.g., caused by extended wear of contact lenses, by eye strain and / or fatigue, by air pollutants, by excessive exposure to the sun, by conjunctivitis, by dry eye syndrome; sensory discomfort associated with oral mucositis; airway (e.g., larynx, trachea, and / or bronchi) tightness, discomfort in the airways (e.g., larynx, trachea, and / or bronchi), choking, cough, and / or dyspnea, e.g., associated with asthma and / or chronic obstructive pulmonary diseases (COPD).

Description

[0001] related application [0002] This application is related to US Patent Application No. 12 / 928,184, filed December 06, 2010, which is hereby incorporated by reference in its entirety. technical field [0003] The present invention relates generally to the fields of coolants and medical treatments. More specifically, the present invention relates to certain anti-nociceptive agents (analgesics, anti-nociceptive agent), such as [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl )-amino]-isopropyl acetate, which is effective, long-lasting and selectively cooling on non-keratinized epithelial tissue versus keratinized epithelial tissue, and for example, on non-keratinized stratified epithelial (NKSE) tissue Treatment (eg, relief of symptoms; improvement) of sensory discomfort is useful; so use for: ocular surface, eyelids, eyelid margins, anterior part of the eye, conjunctiva, lacrimal system, epicorneal membrane, or cornea, lining of the mouth, inside of the lips Partial...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C233/63A61K31/223A61P11/00A61P27/02
CPCA61P11/00A61P11/14A61P17/04A61P27/02C07B2200/07C07C233/63C07C2601/14A61K31/223
Inventor 魏德烽
Owner AXALBION SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products